Literature DB >> 19423561

A corticotroph pituitary adenoma as the initial presentation of familial glucocorticoid deficiency.

Isabelle Benoit1, Delphine Drui, Lucy Chaillous, Benoît Dupas, Jean-François Mosnier, Bernard Charbonnel, Bertrand Cariou.   

Abstract

UNLABELLED: CONTEXT; Familial glucocorticoid deficiency (FGD) is a rare autosomal recessive ACTH-resistance syndrome characterized by glucocorticoid deficiency in the absence of mineralocorticoid deficiency. Here, we report the case of a young woman with a corticotroph pituitary adenoma as the initial presentation of FGD. CASE REPORT: A 15-year-old girl was referred to our institution for a 16 mm pituitary adenoma associated with glucocorticoid deficiency. Clinical and biological features were evocative of FGD. DNA sequencing did not identify mutations in either the melanocortin 2 receptor (MC2R) or the MC2R accessory protein genes, indicating type 3 FGD. Despite adequate glucocorticoid replacement, plasma ACTH levels remained increased and pituitary magnetic resonance imaging (MRI) showed a progression of the tumour size resulting in optic chiasm compression with intra-tumoural haemorrhaging. When the patient was 26 years old, it was decided that she would undergo transsphenoidal surgery. The histomorphological analysis identified a well-individualized pituitary adenoma immunoreactive for ACTH. The proband's sister also exhibited type 3 FGD associated with pituitary hyperplasia upon MRI.
CONCLUSION: This case highlights the relationship between FGD and hyperplasia of ACTH-producing cells, potentially leading to histologically proven pituitary corticotroph adenomas. This observation raises the question of the pituitary MRI's significance in the follow-up of FGD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19423561     DOI: 10.1530/EJE-09-0100

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  2 in total

Review 1.  The glucocorticoid receptor and its expression in the anterior pituitary and the adrenal cortex: a source of variation in hypothalamic-pituitary-adrenal axis function; implications for pituitary and adrenal tumors.

Authors:  George Briassoulis; Svetozar Damjanovic; Paraskevi Xekouki; Hervé Lefebvre; Constantine A Stratakis
Journal:  Endocr Pract       Date:  2011 Nov-Dec       Impact factor: 3.443

2.  Predicted Benign and Synonymous Variants in CYP11A1 Cause Primary Adrenal Insufficiency Through Missplicing.

Authors:  Avinaash Maharaj; Federica Buonocore; Eirini Meimaridou; Gerard Ruiz-Babot; Leonardo Guasti; Hwei-Ming Peng; Cameron P Capper; Neikelyn Burgos-Tirado; Rathi Prasad; Claire R Hughes; Ashwini Maudhoo; Elizabeth Crowne; Timothy D Cheetham; Caroline E Brain; Jenifer P Suntharalingham; Niccolò Striglioni; Bilgin Yuksel; Fatih Gurbuz; Sangay Gupta; Robert Lindsay; Robert Couch; Helen A Spoudeas; Tulay Guran; Stephanie Johnson; Dallas J Fowler; Louise S Conwell; Aideen M McInerney-Leo; Delphine Drui; Bertrand Cariou; Juan P Lopez-Siguero; Mark Harris; Emma L Duncan; Peter C Hindmarsh; Richard J Auchus; Malcolm D Donaldson; John C Achermann; Louise A Metherell
Journal:  J Endocr Soc       Date:  2018-10-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.